13F filing recap · Q2 2022

What did ARK Invest buy in Q2 2022?

Reported stock-position changes between this filing and the previous one. US-listed stocks across every ARK-managed account, including accounts that belong to no fund below.

Stock value

$16.84B

Positions

336

Estimated turnover

12.0%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

DKNGDraftkings Inc.MIXED CORP ACTION$342.49Mreported value+25.28M shares SAUHFStraumann Holding AG$6.66Mreported value+52.3K shares GMGeneral Motors Company$5.84Mreported value+151.1K shares SLGCWSomalogic Inc$274.0Kreported value+300.0K shares MKCMccormick & Company, Incorporated$161.0Kreported value+1.7K shares IWFiShares Trust$137.0Kreported value+574 shares SPYSPDR S&P 500 ETF Trust$32.0Kreported value+78 shares

Increased positions

ZMZoom Communications, Inc.$1.03Breported value+1.16M shares+13.8%ROKURoku, Inc.$962.72Mreported value+1.87M shares+22.6%XYZBlock, Inc.$799.46Mreported value+829.1K shares+10.0%EXASExact Sciences Corporation$745.74Mreported value+647.8K shares

Reduced positions

TSLATesla, Inc.$1.09Breported value-150.9K shares-9.5%SPOTSpotify Technology S.a.$230.43Mreported value-2.34M shares-53.4%IONSIonis Pharmaceuticals, Inc.$171.69Mreported value-1.47M shares-23.8%TRMBTrimble Inc.$139.64Mreported value-192.5K shares

Exited positions

DKNGDraftkings Inc.MIXED CORP ACTION$455.92Mprior reported value-23.42M shares-100.0%SLGCUSDSomalogic Inc$83.33Mprior reported value-10.39M shares-100.0%CSTLCastle Biosciences, Inc.$52.49Mprior reported value-1.17M shares-100.0%SAUHYStraumann Holding AG$8.35M